Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 7, 2015Combined Technologies from BD, CareFusion Create End-to-End IV Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve...
-
Dec 2, 2015Visit the "BD Leadership Theater" to hear how health systems improve and advance quality and safety across the continuum of care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and CareFusion, a BD company, will present its combined, strengthened solutions together as one company,...
-
Nov 23, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.66 cents per common share, an increase of 10.0 percent from the previous quarter....
-
Nov 12, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Stifel 2015 Healthcare Conference Tuesday, November 17,...
-
Nov 7, 2015American Association for Respiratory Care (AARC) Presents Award at Annual Congress
TAMPA, Fla., Nov. 7, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory...
-
Nov 6, 2015
TAMPA, Fla., Nov. 6, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or...
-
Nov 5, 2015AirLife to Offer Nasal High Flow Interfaces from ResMed
SAN DIEGO, CA, Nov. 5, 2015/PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute...
-
Nov 4, 2015- Announces full fiscal year adjusted revenues of $10.302 billion, an increase of 22.0 percent, or 29.5 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 5.3 percent for the full year. As reported, full-year revenues increased 21.7 percent to $10.282 billion.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended...
-
Oct 26, 2015Companies to Establish Interoperability between Hemodynamic Monitoring Systems and Infusion Devices
SAN DIEGO and IRVINE, Calif., October 23, 2015 – Edwards Lifesciences and CareFusion, a BD company, today announced a collaboration agreement to enable interoperability between patient...
-
Oct 26, 2015Companies to Establish Interoperability between Hemodynamic Monitoring Systems and Infusion Devices
SAN DIEGO and IRVINE, Calif., October 23, 2015 – Edwards Lifesciences and CareFusion, a BD company, today announced a collaboration agreement to enable interoperability between patient...